ArticleCancer immunology, immunotherapy : CII2018

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.

Marie-Léa Gauci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.